We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

High Blood Sugar During Pregnancy Increases Risk of Diabetes

By LabMedica International staff writers
Posted on 02 Oct 2018
Print article
Image: A pregnant woman undergoing a blood test for gestational diabetes (Photo courtesy of US National Institute of Diabetes and Digestive and Kidney Diseases).
Image: A pregnant woman undergoing a blood test for gestational diabetes (Photo courtesy of US National Institute of Diabetes and Digestive and Kidney Diseases).
Mothers with elevated blood glucose during pregnancy, even if not high enough to meet the traditional definition of gestational diabetes, were significantly more likely to have developed type 2 diabetes a decade after pregnancy than their counterparts without high blood glucose.

In a recent study of children born to mothers with elevated or normal glucose, there was no statistical significant difference between the two groups of children in terms of their combined overweight and obesity, which was the study’s primary outcome. However, when obesity was measured alone, children of mothers with elevated blood glucose were significantly more likely to be obese.

An international team of scientists led by those at the Northwestern University Feinberg School of Medicine (Chicago, IL, USA) examined associations of gestational diabetes (GD) with maternal glucose metabolism and childhood adiposity 10 to 14 years’ postpartum. The follow-up study evaluated the long-term outcomes of 4,697 mothers and 4,832 children; study visits occurred between February 13, 2013, and December 13, 2016. Gestational diabetes was defined post hoc using criteria consisting of one or more of the following 75-g oral glucose tolerance test results (fasting plasma glucose ≥92 mg/dL; 1-hour plasma glucose level ≥180 mg/dL; 2-hour plasma glucose level ≥153 mg/dL).

The scientists reported that the criteria for GD were met by 14.3% (672/4,697) of mothers overall and by 14.1% (683/4,832) of mothers of participating children. Among mothers with GD, 52.2% (346/663) developed a disorder of glucose metabolism versus 20.1% (791/3,946) of mothers without GD (odds ratio [OR], 3.44; risk difference [RD], 25.7%). Among children of mothers with GD, 39.5% (269/681) were overweight or obese and 19.1% (130/681) were obese versus 28.6% (1,172/4,094) and 9.9% (405/4,094), respectively, for children of mothers without GD. Among women with elevated blood glucose during pregnancy, nearly 11% had type 2 diabetes at the follow-up study visit 10 to 14 years after childbirth and about 42% had prediabetes. Of their counterparts who did not have elevated blood glucose during pregnancy, about 2% had type 2 diabetes and about 18% had prediabetes.

The authors concluded that among women with GD identified by contemporary criteria compared with those without it, GD was significantly associated with a higher maternal risk for a disorder of glucose metabolism during long-term follow-up after pregnancy. Barbara Linder, MD, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, Bethesda, MD, USA), said, “The differences in mothers and their children due to the mother’s higher blood glucose are very concerning. Even accounting for the mother’s weight, glucose had an independent effect. Our findings add to the motivation to find ways to help women at high risk for gestational diabetes who are or plan to get pregnant to take steps to reduce their risk.” The study was published on September 11, 2018, in the Journal of the American Medical Association.

Related Links:
Northwestern University Feinberg School of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more